Is neoadjuvant androgen deprivation therapy beneficial in prostate cancer treated with definitive radiotherapy?

PURPOSE: To determine whether neoadjuvant androgen deprivation therapy (NADT) improves clinical outcomes in patients with prostate cancer treated with definitive radiotherapy. MATERIALS AND METHODS: We retrospectively reviewed medical records of 201 patients with prostate cancer treated with radioth...

Descripción completa

Detalles Bibliográficos
Autores principales: Eom, Keun-Yong, Ha, Sung W, Lee, Eunsik, Kwak, Cheol, Lee, Sang Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282999/
https://www.ncbi.nlm.nih.gov/pubmed/25568853
http://dx.doi.org/10.3857/roj.2014.32.4.247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282999/
https://www.ncbi.nlm.nih.gov/pubmed/25568853
http://dx.doi.org/10.3857/roj.2014.32.4.247

Ejemplares similares